This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1990 Feb 15;112(4):241-2.

doi: 10.7326/0003-4819-112-4-241.

Soluble CD4: the first step

E C Tramont, R R Redfield

PMID: 2297202
DOI: 10.7326/0003-4819-112-4-241

Editorial

Soluble CD4: the first step

E C Tramont et al. Ann Intern Med. 1990.

. 1990 Feb 15;112(4):241-2.

doi: 10.7326/0003-4819-112-4-241.

Authors

E C Tramont, R R Redfield

PMID: 2297202
DOI: 10.7326/0003-4819-112-4-241

No abstract available

PubMed Disclaimer

Comment on

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.
Schooley RT, Merigan TC, Gaut P, Hirsch MS, Holodniy M, Flynn T, Liu S, Byington RE, Henochowicz S, Gubish E, et al. Schooley RT, et al. Ann Intern Med. 1990 Feb 15;112(4):247-53. doi: 10.7326/0003-4819-112-4-247. Ann Intern Med. 1990. PMID: 2297203
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
Kahn JO, Allan JD, Hodges TL, Kaplan LD, Arri CJ, Fitch HF, Izu AE, Mordenti J, Sherwin JE, Groopman JE, et al. Kahn JO, et al. Ann Intern Med. 1990 Feb 15;112(4):254-61. doi: 10.7326/0003-4819-112-4-. Ann Intern Med. 1990. PMID: 2297204

Similar articles

Human recombinant soluble CD4 therapy.
Gerety RJ, Hanson DG, Thomas DW. Gerety RJ, et al. Lancet. 1989 Dec 23-30;2(8678-8679):1521. doi: 10.1016/s0140-6736(89)92960-7. Lancet. 1989. PMID: 2574789 Clinical Trial. No abstract available.
Therapeutic strategies employing CD4, the HIV receptor.
Ashorn P, Moss B, Berger EA. Ashorn P, et al. Adv Exp Med Biol. 1992;312:71-81. doi: 10.1007/978-1-4615-3462-4_6. Adv Exp Med Biol. 1992. PMID: 1514446 Review. No abstract available.
The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia.
Schacker T, Coombs RW, Collier AC, Zeh JE, Fox I, Alam J, Nelson K, Eggert E, Corey L. Schacker T, et al. J Infect Dis. 1994 Jan;169(1):37-40. doi: 10.1093/infdis/169.1.37. J Infect Dis. 1994. PMID: 8277195 Clinical Trial.
[CD4-derivatives therapy of HIV carriers].
Mizukami T, Mitsuya H. Mizukami T, et al. Nihon Rinsho. 1993 Sep;51 Suppl:327-33. Nihon Rinsho. 1993. PMID: 8271399 Japanese. No abstract available.
The molecular basis of anti-retroviral therapy.
Weber J. Weber J. J Antimicrob Chemother. 1993 Dec;32(6):789-92. doi: 10.1093/jac/32.6.789. J Antimicrob Chemother. 1993. PMID: 7511578 Review. No abstract available.

See all similar articles

Cited by

Simple assay to screen for inhibitors of interaction between the human immunodeficiency virus envelope glycoprotein and its cellular receptor, CD4.
Chams V, Idziorek T, Maddon PJ, Klatzmann D. Chams V, et al. Antimicrob Agents Chemother. 1992 Feb;36(2):267-72. doi: 10.1128/AAC.36.2.267. Antimicrob Agents Chemother. 1992. PMID: 1605591 Free PMC article.
Viral multiplicity of attachment and its implications for human immunodeficiency virus therapies.
Spouge JL. Spouge JL. J Virol. 1994 Mar;68(3):1782-9. doi: 10.1128/JVI.68.3.1782-1789.1994. J Virol. 1994. PMID: 8107240 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program